Novel time-synchronized immune-guided partial tumor irradiation: proof of principle trial

Background and purpose - Radiotherapy for bulky tumors often results in palliation with suboptimal outcomes. The prognosis is worsened by immunosuppression caused by radio-chemotherapy, negatively impacting on survival. Novel Partial Tumor Irradiation (PTI) was designed to spare the Peritumoral Immu...

Full description

Saved in:
Bibliographic Details
Main Authors: Tubin, Slavisa (Author) , Ashdown, M. L. (Author) , Ahmed, M. M. (Author) , Guha, C. (Author) , Salerno, G. (Author) , Celedin, B. (Author) , Trummer, B. (Author) , Demschar, S. (Author) , Raunik, W. (Author)
Format: Article (Journal)
Language:English
Published: October 2024
In: Radiotherapy and oncology
Year: 2024, Volume: 199, Pages: 1-9
ISSN:1879-0887
DOI:10.1016/j.radonc.2024.110442
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.radonc.2024.110442
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814024007126
Get full text
Author Notes:S. Tubin, M. L. Ashdown, M. M. Ahmed, C. Guha, G. Salerno, B. Celedin, B. Trummer, S. Demschar, W. Raunik

MARC

LEADER 00000caa a2200000 c 4500
001 1925924793
003 DE-627
005 20250913141525.0
007 cr uuu---uuuuu
008 250519s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.radonc.2024.110442  |2 doi 
035 |a (DE-627)1925924793 
035 |a (DE-599)KXP1925924793 
035 |a (OCoLC)1528045221 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tubin, Slavisa  |e VerfasserIn  |0 (DE-588)1349758736  |0 (DE-627)1909915831  |4 aut 
245 1 0 |a Novel time-synchronized immune-guided partial tumor irradiation  |b proof of principle trial  |c S. Tubin, M. L. Ashdown, M. M. Ahmed, C. Guha, G. Salerno, B. Celedin, B. Trummer, S. Demschar, W. Raunik 
264 1 |c October 2024 
300 |b Illustrationen 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 26. Juli 2024, Artikelversion: 31. Juli 2024 
500 |a Gesehen am 19.05.2025 
520 |a Background and purpose - Radiotherapy for bulky tumors often results in palliation with suboptimal outcomes. The prognosis is worsened by immunosuppression caused by radio-chemotherapy, negatively impacting on survival. Novel Partial Tumor Irradiation (PTI) was designed to spare the Peritumoral Immune Microenvironment (PIM) and to be delivered synchronously with immune activity peaks, thus enhancing both local and distant tumor control through immunostimulation. - Materials and methods - Present proof-of-principle trial enrolled 26 patients with bulky tumors, comparing outcomes between treatments administered at immune activity peaks versus troughs. The primary endpoint was local-bystander and distal-abscopal response-rate. Secondary endpoints included overall-, progression-free-, cancer-specific survival, neoadjuvant and immunomodulatory potential. - Results - All measured outcomes were significantly influenced by treatment-timing. The bystander and abscopal response rates were 77% and 41%, respectively. PTI significantly upregulated pro-inflammatory and cell-death-inducing pathways improving the efficacy of radiotherapy by highly complex tumors. - Conclusions - This study highlights the profound impact PTI can have on a highly palliative patient cohort previously deemed beyond therapeutic hope. With 41 % of these patients still alive after a median follow-up of 50 months, PTI offers a potential lifeline for those facing advanced, treatment-resistant cancers. This approach generated also distant immunogenic anti-tumor responses, offering a promising new avenue for the treatment of advanced cancers. 
650 4 |a Abscopal effect 
650 4 |a Bystander effect 
650 4 |a Immunomodulation 
650 4 |a Partial tumor irradiation 
700 1 |a Ashdown, M. L.  |e VerfasserIn  |4 aut 
700 1 |a Ahmed, M. M.  |e VerfasserIn  |4 aut 
700 1 |a Guha, C.  |e VerfasserIn  |4 aut 
700 1 |a Salerno, G.  |e VerfasserIn  |4 aut 
700 1 |a Celedin, B.  |e VerfasserIn  |4 aut 
700 1 |a Trummer, B.  |e VerfasserIn  |4 aut 
700 1 |a Demschar, S.  |e VerfasserIn  |4 aut 
700 1 |a Raunik, W.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Radiotherapy and oncology  |d Amsterdam [u.a.] : Elsevier Science, 1983  |g 199(2024) vom: Okt., Artikel-ID 110442, Seite 1-9  |h Online-Ressource  |w (DE-627)306710110  |w (DE-600)1500707-8  |w (DE-576)082435731  |x 1879-0887  |7 nnas  |a Novel time-synchronized immune-guided partial tumor irradiation proof of principle trial 
773 1 8 |g volume:199  |g year:2024  |g month:10  |g elocationid:110442  |g pages:1-9  |g extent:9  |a Novel time-synchronized immune-guided partial tumor irradiation proof of principle trial 
856 4 0 |u https://doi.org/10.1016/j.radonc.2024.110442  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0167814024007126  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250519 
993 |a Article 
994 |a 2024 
998 |g 1349758736  |a Tubin, Slavisa  |m 1349758736:Tubin, Slavisa  |d 910000  |d 911400  |e 910000PT1349758736  |e 911400PT1349758736  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1925924793  |e 4725741140 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"October 2024"}],"id":{"eki":["1925924793"],"doi":["10.1016/j.radonc.2024.110442"]},"name":{"displayForm":["S. Tubin, M. L. Ashdown, M. M. Ahmed, C. Guha, G. Salerno, B. Celedin, B. Trummer, S. Demschar, W. Raunik"]},"physDesc":[{"extent":"9 S.","noteIll":"Illustrationen"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1983-","publisher":"Elsevier Science","dateIssuedKey":"1983"}],"id":{"eki":["306710110"],"zdb":["1500707-8"],"issn":["1879-0887"]},"pubHistory":["1.1983 -"],"part":{"text":"199(2024) vom: Okt., Artikel-ID 110442, Seite 1-9","volume":"199","extent":"9","year":"2024","pages":"1-9"},"titleAlt":[{"title":"The green journal"}],"note":["Gesehen am 30.05.15","Ungezählte Beil.: Supplement"],"disp":"Novel time-synchronized immune-guided partial tumor irradiation proof of principle trialRadiotherapy and oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"306710110","title":[{"title_sort":"Radiotherapy and oncology","title":"Radiotherapy and oncology","subtitle":"journal of the European Society for Therapeutic Radiology and Oncology"}]}],"title":[{"title_sort":"Novel time-synchronized immune-guided partial tumor irradiation","title":"Novel time-synchronized immune-guided partial tumor irradiation","subtitle":"proof of principle trial"}],"person":[{"family":"Tubin","given":"Slavisa","display":"Tubin, Slavisa","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ashdown, M. L.","given":"M. L.","family":"Ashdown"},{"role":"aut","display":"Ahmed, M. M.","roleDisplay":"VerfasserIn","given":"M. M.","family":"Ahmed"},{"display":"Guha, C.","roleDisplay":"VerfasserIn","role":"aut","family":"Guha","given":"C."},{"display":"Salerno, G.","roleDisplay":"VerfasserIn","role":"aut","family":"Salerno","given":"G."},{"role":"aut","display":"Celedin, B.","roleDisplay":"VerfasserIn","given":"B.","family":"Celedin"},{"family":"Trummer","given":"B.","roleDisplay":"VerfasserIn","display":"Trummer, B.","role":"aut"},{"display":"Demschar, S.","roleDisplay":"VerfasserIn","role":"aut","family":"Demschar","given":"S."},{"display":"Raunik, W.","roleDisplay":"VerfasserIn","role":"aut","family":"Raunik","given":"W."}],"note":["Online veröffentlicht: 26. Juli 2024, Artikelversion: 31. Juli 2024","Gesehen am 19.05.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1925924793","language":["eng"]} 
SRT |a TUBINSLAVINOVELTIMES2024